medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2008, Number 4

<< Back Next >>

Rev Mex Oftalmol 2008; 82 (4)

Esclerectomía profunda en el manejo del glaucoma crónico de ángulo abierto

Lozano-Tamez A, Brechtel-Bindel M, Castillo-Ortiz C, Fuente-Torres MA

Language: Spanish
References: 10
Page: 251-255
PDF size: 92.10 Kb.


ABSTRACT

Purpose: To assess the decrease of intraocular pressure and the frequency of transoperative and postoperative complications in patients who underwent deep sclerectomy.
Material and methods: Thirty three eyes of 25 patients with diagnosis of chronic open angle glaucoma that underwent surgery from January 2004 to July 2006 were included. The preoperative intraocular pressure was evaluated at the first day and at 3, 6 and 12 months; preoperative antiglaucomatous medication used previously and at 12 months; preoperative visual capacity at first day and at 12 months; the filtering bleb and media deviation of the visual field test and the frequency of trans and postoperative complications.
Results: In the first postoperative day the mean intraocular pressure was 5.30±2.89 mmHg, at the third month it was 15.78±6.72 mmHg, at the sixth month 14.84±6.27 mmHg, and at the first year 12.15±3.07 mmHg. The number of antiglaucomatous medication at one year was 1.00 vs. 2.75 preoperative medication (p=0.023). In the follow up period of one year 61.0% had no changes in lines of vision and 33% had one line of vision loss.
Conclusions: Deep sclerectomy is effective in the treatment of chronic open angle glaucoma, obtains goal intraocular pressure and avoids the serious complications of the trabeculectomy.


REFERENCES

  1. Allingham RR. Shields’ Textbook of Glaucoma. Lippincott Williams & Wilkins; 5° edition. 2004.

  2. Stamper RL. Becker-Shaffer’s Diagnosis and Therapy of the Glaucomas. Elsevier. 7° edition. 2005.

  3. Goldsmith J. Nonpenetrating glaucoma surgery. Ophthalmol Clin N Am 2005; 18:443-460.

  4. El Sayyad F. Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma. Ophthalmology 2000; 107(9):1671-1674.

  5. Cillino S. Deep sclerectomy versus punch trabeculectomy: effect of low dosage mitomycin C. Ophthalmologica 2005; 219(5):281-286.

  6. Anand N. Deep sclerectomy augmented with mitomycin C. Eye 2005; 19(4):442-50.

  7. Rebolleda G. Deep sclerectomy with mitomycin C in failed trabeculectomy. Ophthalmology 2007; 21(1):23-8.

  8. Mermoud A. Nd:YAG goniopuncture after deep sclerectomy with collagen implant. Ophthalmoc Surg Lasers 1999; 30:120-5.

  9. Wojtulewicz M. Subconjuntival application of 5-fluorouracil (5-fu) following surgical treatment of glaucoma with deep sclerectomy—indications, complications and initial evaluation of effectiveness. Klin Oczna 2005; 107(4-6):232-5.

  10. Shaarawy T. Deep sclerectomy in one eye vs. deep sclerectomy with collagen implant in the contralateral eye of the same patient: long term follow up. Eye 2005; 19(3):298-302.




2020     |     www.medigraphic.com